International Programs and Export Development
|Translation ||Currency Conversion ||Trade Finance |
FedEx Shipping Discount
Available to IHIF Members
on Translation Services through
Available to IHIF Members
FedEx Express® international:
Up to 35% savings on select services
| HS Code Search||Connect Around The World ||U.S. Export Programs |
Indiana District Office, US Department of Commerce
|News||Special Offers and Events ||Travel Visa Assistance|
a whitepaper by Joan Meyer, PhD, Operational Strategy
Export Indiana Fellowship - Help Plan Your International Strategy
Market Research - 2015 Country Commercial Guides
FierceBiotech ebook - Navigating the Logistics of Global Clinical Trials
| Trade Leads|
The Indiana Health Industry Forum (IHIF) is pleased to begin its partnership with the Federation of Israeli Chambers of Commerce (FICC) and has begun an effort to expand trade and partnership opportunities between member companies of both organizations.
TL 4 -Resuscitation, Trauma, and Emergency Medicine Products
Israeli company seeks to represent US manufacturers of resuscitation, trauma, and emergency medicine products. Also includes medical equipment for simulation and training for medical provider teams. The company also distributes products for psoriasis, aesthetic and plastic surgery, electrical diagnostic equipment, training (first aid, CPR, and Fire and Safety), and telemedicine. Please contact IHIF for additional information
TL 5 - Diagnostic Tools, Tests, CRO Services, Tele-pathology
Chinese clinical laboratory with national service network seeks novel, FDA approved diagnostic tools and/or tests for use in China. Company also seeking partnerships for international clinical lab testing services, (CRO) and comprehensive genomic analysis based on NGS technology (tumor, microbial, PGD & PGS,etc.). Company also seeks partnership for international tele-pathology service, with cooperation from renowned US medical centers. For more information, please contact IHIF.
| Australia is the world's second leading source of innovation in the health sciences, behind Europe and in front of the US. However, due to the limited size of the market, from both a population, talent, and financial resource standpoint, Australian companies quickly have to grow into larger markets. The Indiana Health Industry Forum works with a contractor in Australia to provide export development services and in-market research. Project fees are assessed on an hourly basis. Services are available to members and non-members.|
Interested in finding partners or suppliers in Australia? Need more information on the Australian market?
IHIF also helps Australian companies find service and manufacturing partners in Indiana and works with the state's economic development community to respond to investment inquiries. Contact IHIF for more information.
|Ausbiotech ||AusBiotech is Australia’s industry organisation, working on behalf of members for more than 25 years to provide representation and services to promote the global growth of Australian biotechnology. AusBiotech is a well-connected network of over 3,000 members in the life sciences, including therapeutics, medical technology (devices and diagnostics), food technology and agricultural, environmental and industrial sectors.|
|Brandwood Biomedical are regulatory affairs consultants who have served the medical devices & IVD industry since 2000. Services include regulatory submissions (TGA, US FDA 510(k), CE, China FDA and Taiwan FDA), postmarket support, ISO 13485 / 21CFR quality systems and clinical evaluation and reimbursement. Our expert multilingual regulatory consultants in Australia, New Zealand & China are led by professionals with international networks and decades of experience to provide seamless regulatory compliance across multiple markets.|
|University of New South Wales: Technology Transfer Office|
|Melbourne Life Sciences at a Glance - Melbourne's expertise in stem cell, infectious diseases, cancer, neuroscience and agricultural biotechnology is internationally recognised.|
|SGS - An Overview of Australia's Regulatory Process for Medical Devices Australia's R&D Tax Incentive|
|Australian scientists grow HIV antibodies in cow's milk|
|Pancreatic stem cells show promise for type 1 diabetes|
Australian researchers have identified pancreatic stem cells that can be converted into insulin-producing cells and found that the cells' number and capacity to become insulin-producers also appeared to increase in response to pancreatic damage. The findings in PLoS ONE may pave the way for new type 1 diabetes treatments, researchers said. Medical News Today (11/14)
|Australia creates database on adverse events tied to medtech|
The Therapeutic Goods Administration in Australia has introduced the Database of Adverse Event Notifications for medical devices, which includes data on adverse events reported to the TGA since July of last year. The database is part of an effort to form the Australia New Zealand Therapeutic Products Agency, a regulatory body that would link the TGA with its New Zealand counterpart. (6/24/13)
|In September 2014, IHIF and the Zhejiang Council for Health Services Promotion signed an MOU to establish a partnership benefitting members of both organizations and offering facilitated access to the Zhejiang health/hospital/medical market. Building on the almost thirty-year history of the Zhejiang Province - Indiana Sister State relationship, this MOU offers IHIF members a unique opportunity to engage with China on a commercial level. Learn more about the MOU here. To find out how your company can access the Zhejiang market, please contact IHIF at firstname.lastname@example.org F|
| Pacific World Trade, Inc.||Working as IHIF's agent in China, Pacific World Trade was one of the first Indiana companies to establish operation in China in 1986. Today, PWT has three offices in China: Beijing, Suzhou, and Hangzhou. PWT’s primary business activities are in the health, automotive, and nuclear industry sectors. PWT co-founded Indiana’s sister-state relationship with Zhejiang Province in 1987 with Governor Robert Orr. PWT has founded more than ten Indiana-Zhejiang sister-cities, including the Indianapolis-Hangzhou relationship.|
| A statutory body established in 1966 under the HKTDC Ordinance (Chapter 1114), the Hong Kong Trade Development Council (HKTDC) is the international marketing arm for Hong Kong-based traders, manufacturers and service providers.|
Our mission is to create opportunities for Hong Kong companies. With our network of more than 40 offices worldwide, and the city’s natural business advantages, we provide a range of services to help global trade and promote Hong Kong as a platform for doing business with China and throughout Asia.
|About Zhejiang Province - September 2014 |
| Medical & Healthcare Equipment Industry in Hong Kong - Report released September 2012|
|Medical Devices and Supplies Product Catalog (May 2014)|
| ChineseMedTech Market Poised for Continued Growth - June 18, 2013 MDDI On-line|
|China Briefing Information and Fact Sheet - US Department of Commerce |
|Expanding in China's MedTech Market: Where to go from here - InVIVO, June 2013|
|Investing in China's Private Healthcare System - PriceWaterhouseCoopers|
|US Department of Commerce - "Doing Business in China Seminar" - April 7, 2016 $25 registration fee - Register - Program Flyer|
|IHIF and the Zhejiang Council for Health Services Promotion are working to intoduce companies and solve challenges across several sectors, including: Health IT, BioBanking, Hospital Pharmacy Management, Medical Devices and Equipment, and Elder Care Solutions. To find out more about how your company can become involved, please contact IHIF at info@IHIF.org.|
|China: A $1T Health Care Market in the Making - Forbes|
UK Trade & Investment (UKTI) works with UK-based businesses to ensure their success in international markets, and encourage the best overseas companies to look to the UK as their global partner of choice.
IHIF works with the UKTI office in Chicago to identify partnerships that benefit both Indiana and UK companies.
|An international network of small-medium sized companies and multiplier organizations. Coordinates one-to-one business meeting events. Open to international partner companies.|
|Manchester is serious about healthcare. We’re building the best medical facilities for our citizens and the most advanced research environments for our businesses. Manchester now has Europe’s largest clinical academic campus following a billion pounds of investment. We’re home to several medical research institutes; Europe’s biggest cancer treatment centre and the largest clinical trials unit in the world.|
|The BioCampus Cologne is developing into a motor of innovation and one of the largest biotechnology parks in Germany. At the centre of the idea are numerous up-and-coming companies from the life science sector, who have settled here since the opening in 2002.|
On an area of more than 254,000 m², it offers a good foundation for growth and is the location of the future for this knowledge-based industry in the heart of Europe. The pre-financed infrastructure and individual settlement concepts offer new perspectives for the growth sector biotechnology. The chance is right here.
|Firalis is a European biotechnology company, developing biomarkers (BM), particularly in the Cardiovascular, Inflammatory and Neurology field, for pre-clinical and clinical applications such as:|
● BM-based detection of potential toxic effects of drugs & drug-candidates
● Identification of patients for whom drug treatment may be toxic
● Selection of responding patients to a given treatment
● Diagnosis of cardiovascular disorders with inflammatory components
Firalis offers bio-analytical services and biomarker-based products to the pharmaceutical industry, biotechnology companies and universities. Using its strong expertise and a cutting-edge laboratory equipment, Firalis develops and delivers solutions for biomarker assays customized to your projects.
|MT Promedt Consulting GmbH is a Germany based regulatory consultancy operating in the international healthcare market (medical device, in vitro diagnostics, pharmaceutical and biotechnology industry). Founded in 1995, the company operates two German offices in St. Ingbert/Saarland and Tornesch/Schleswig-Holstein and a US office in Salt Lake City/Utah.|
UK Biopharma and Healthcare Market - Source: UKTI
Free White Paper on EU E-Labeling Requirements from Merrill Brink International
|The Federation of Israeli Chambers of Commerce (FICC) was founded in 1919 as an independent and non-profit entity. It is the leading economic organization representing the trade and service sector, the largest sector in Israel. The FICC serves as roof organization to over 5000 businesses and organizations operating in more than 120 divisions which represent various economic branches including export, import, trade, real estate, financial and business services.|
|The EDI team specializes in market research, trade development, market penetration, strategic information and feasibility studies for the Middle East region. Our reach covers Israel, Cyprus, Greece, Turkey, North Africa and the Persian Gulf. We also facilitate business meetings, missions, trade events and networking in the region. EDI promotes foreign direct investment by Israeli companies in North America, Europe and elsewhere. |
Israel Trade and Economic Office - Midwest Region
The Israeli Foreign Trade Administration is responsible for managing and directing the international trade policy of the State of Israel and promoting Israel’s international business exchange. The Missions’ primary objectives are the promotion of trade and exportation, initiating and maintaining trade agreements for the improvement of Israel’s trade conditions, attracting and encouraging foreign investments and creating strategic cooperation with foreign companies, organizations and government agencies.
| EDI Fortnightly||A review of Israeli and Regional Business, News, and Developments. Newsletter sign-up available|
| Country Commercial Guide||A detailed guide on business practices and market conditions in Israel. Prepared by the U.S. Commercial Service.|
|Market Research - Health Technologies||Health technology best prospects report (excerpt from Country Commercial Guide).|
| U.S.-Israel Business Initiative Background|
|What is planned for May 20-22 is for the Biomed and High-tech conferences to be run side-by-side; each exhibiting its own sectors and activities in separate venues, with the audience free to move from one location to the other without limitation. The Office of the Chief Scientist's annual R&D Conference will also merge with Israel Innovation Week, bringing the government perspectives and exhibitions of the OCS programs into the new format. The Biomed and High-tech venues will include lectures, company presentations and exhibitions. While each event will cater to the participants of its respective agenda, the event will also include joint sessions covering topics of mutual interest to the entire advanced technology industries including: perspectives of innovation and R&D policy and the convergence of technologies between High-tech and Biomed and other factors of the Israeli eco-sector.|
June 23, 2014 -San Diego, CA
The Government of Israel Economic Mission to the West Coast will be hosting the Israel Delegation from the BIO 2014 International Convention for the North America-Israel Biotech Conference. In addition to presentations from Israeli companies, the Chief Scientist of Israel will speak about life science R&D in the State of Israel, along with a panel discussion about challenges, synergies and opportunities for increased cooperation and business partnerships between Israel and North America. Joining us on the panel will include top life science executives from leading global life science companies.
|M-Systems, an Israeli company that created the USB stick, is making inroads in the medical-device arena. Founder Dov Moran has set up a company focusing on a blood-glucose-monitoring system for people with diabetes and has also offered seed funding to Sensible Medical, a company developing a device used to monitor lung fluids in certain heart patients. Reuters (12/26)|
|The Indiana Health Industry Forum and the Japan America Society of Indiana (JASI) have partnered to assist members of both organizations to further explore opportunities between markets.|
|IHIF and JASI work cooperatively with the Japanese External Trade Organization (JETRO), a government-related organization that works to promote mutual trade and investment between Japan and the rest of the world. Originally established in 1958 to promote Japanese exports abroad, JETRO's core focus in the 21st century has shifted toward promoting foreign direct investment into Japan and helping small to medium size Japanese firms maximize their global export potential.|
| Healthcare Business In Japan||Market updates for the medical device and pharma/biotechnology sectors|
|Building Bio Bridges - A joint program hosted by IHIF and the Japan-America Society of Indiana. Series Announcement Coming Soon!|
Eisai scored FDA approval for its new epilepsy drug Fycompa. It's the first seizure drug of its kind--a glutamate receptor antagonist--and a blockbuster hopeful for the Japanese drugmaker, which is aiming for top-three status in the seizure drug market.
Analysts have said Fycompa could hit $500 million in sales by 2015 and eventually break the $1 billion blockbuster barrier.
|Japanese Regulators Clarify Proposed Changes To Medical Device Regulatory System|
|Consulate General of the Republic of Indonesia in Chicago Economic Affairs Division|
211 W. Wacker Drive, 8th Fl
Chicago, IL 60606
TRADEXPO Indonesia - October 16-20-2013 - Jakarta International Expo, Kemayoran, Indonesia
TRADEXPO Indonesia (TEI) is an annual trade exhibition organized by the ministry of Trade of the Republic of Indonesia. The Expo is aimed to promote quality Indonesian-made products and services to the global market, to better develop business and investment networking, and to exchange potentials and opportunities for investment in Indonesia's industrial sector. This year's show is expected to host over 600 exhibitors in 2,000 booths.
|Artes signs vaccines-development deal with Indonesian firm|
Artes Biotechnology and Bio Farma, a vaccine- and antisera-maker, agreed to collaborate on vaccine development. The deal involves the use of Artes' Metavax viruslike particle technology. Genetic Engineering & Biotechnology News (7/15)